RxDoctor Payments DataLook up a doctor →

Virginia Kellner, MD

Neurology · Lafayette, LANPI 1407084528

Payments from drug & device makers

$17,538in general payments, 2019–2025

Across 1,228 payments — averaging $14.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$4K
  • Neurocrine Biosciences, Inc.$1K
  • Acadia Pharmaceuticals Inc$945
  • Teva Pharmaceuticals USA, Inc.$910
  • EMD Serono, Inc.$806
  • Amgen$724
  • plus $9K from 53 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)280$3,551
Neurocrine Biosciences, Inc.131$1,442
Acadia Pharmaceuticals Inc84$945
Teva Pharmaceuticals USA, Inc.74$910
EMD Serono, Inc.40$806
Amgen(2 entities)41$724
UCB, Inc.43$661
Sunovion Pharmaceuticals Inc.62$622
Lundbeck LLC38$617
Novartis27$606
AstraZeneca(2 entities)24$505
Pfizer37$468
Biogen29$435
Neurelis, Inc.20$404
Lilly USA, LLC25$393
Sanofi22$389
CSL Behring21$351
Argenx US, Inc.14$288
Amneal Pharmaceuticals LLC23$271
Mallinckrodt Hospital Products Inc.15$254
MDD US Operations, LLC12$237
Eisai Inc.10$207
Johnson & Johnson7$196
Biohaven Pharmaceuticals, Inc.20$184
Upsher-smith Laboratories LLC11$166
Kyowa Kirin, Inc.11$158
Mallinckrodt Enterprises LLC12$148
ANI Pharmaceuticals, Inc.8$134
Otsuka America Pharmaceutical, Inc.7$131
SK Life Science, Inc.6$130
Tanabe Pharma America, Inc.7$124
TG Therapeutics, Inc.6$114
Takeda Pharmaceuticals U.S.A., Inc.4$101
Axsome Therapeutics, Inc.5$79
Azurity Pharmaceuticals, Inc.4$76
Sumitomo Pharma America, Inc.9$74
Genentech USA, Inc.4$66
Adamas Pharmaceuticals, Inc.4$65
GE HealthCare4$57
Promius Pharma LLC3$48
Vertical Pharmaceuticals, LLC3$45
Acorda Therapeutics, Inc2$32
Abbott1$32
Bristol Myers Squibb2$27
Arbor Pharmaceuticals, Inc.2$27
Silk Road Medical, Inc.1$26
Grifols USA, LLC1$25
Tonix Medicines, Inc.1$24
Medtronic1$19
Alnylam Pharmaceuticals Inc.1$19
Vanda Pharmaceuticals Inc.1$19
Nevro Corp.1$15
Supernus Pharmaceuticals, Inc.1$15
Springworks Therapeutics, Inc.1$14
Zyla Life Sciences, Inc.1$14
Boston Scientific1$14
Piramal Critical Care1$14
Avanir Pharmaceuticals, Inc.1$13
Janssen Scientific Affairs, LLC1$6

How this compares

$17,538 in reported general payments places this provider in the 80th percentile of 225 neurology providers in Louisiana.

See all neurology providers in Louisiana

Medicare billing

Part B allowed, 2024
$96,912
Medicare patients
595
Services billed
891

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Lafayette

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →